Literature DB >> 3290287

Use of an autologous antigen in the serologic testing of patients with erythema migrans of Lyme disease.

B W Berger1, A B MacDonald, J L Benach.   

Abstract

We attempted to detect an early rise in antibody titers to Borrelia burgdorferi in the serum of patients with erythema migrans of Lyme disease by utilizing B. burgdorferi isolates obtained from patients' own skin lesions instead of the B31 reference strain. B. burgdorferi was isolated from nine of 23 skin biopsy specimens submitted for culture. Elevated antibody titers were not detected in any of the 23 acute serum samples by immunofluorescence assay. The antigens derived from patient isolates were no more effective than the reference strain in detecting antibodies in patients with early Lyme disease.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3290287     DOI: 10.1016/s0190-9622(88)70129-2

Source DB:  PubMed          Journal:  J Am Acad Dermatol        ISSN: 0190-9622            Impact factor:   11.527


  4 in total

1.  Antibody response against autologous and heterologous isolates of Borrelia burgdorferi in four patients with Lyme neuroborreliosis.

Authors:  M Karlsson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-09       Impact factor: 3.267

2.  2nd European Symposium on Lyme Borreliosis. A NATO advanced research workshop. United Kingdom, 19-20 May 1993. Abstracts.

Authors: 
Journal:  Ann Rheum Dis       Date:  1993-05       Impact factor: 19.103

3.  Serodiagnosis of Lyme borreliosis by Borrelia burgdorferi sensu stricto, B. garinii, and B. afzelii western blots (immunoblots).

Authors:  G L Norman; J M Antig; G Bigaignon; W R Hogrefe
Journal:  J Clin Microbiol       Date:  1996-07       Impact factor: 5.948

4.  Comparison of different strains of Borrelia burgdorferi sensu lato used as antigens in enzyme-linked immunosorbent assays.

Authors:  L A Magnarelli; J F Anderson; R C Johnson; R B Nadelman; G P Wormser
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.